Rare primary non-neuroendocrine tumours of the sella
Federico Roncaroli(Manchester Academic Health Science Centre), Kanna Gnanalingham, Debajyoti Chatterjee(Post Graduate Institute of Medical Education and Research), Chiara Villa(Centre National de la Recherche Scientifique), Caterina Giannini(Mayo Clinic), Mariam Mansour(Délégation Paris 5), Marco Faustini‐Fustini
Cited by 6
Related Papers
Intertumoral Heterogeneity within Medulloblastoma Subgroups
|Cancer Cell|2017|1.3k
Clinical Characteristics and Therapeutic Responses in Patients with Germ-Line<i>AIP</i>Mutations and Pituitary Adenomas: An International Collaborative Study
|The Journal of Clinical Endocrinology & Metabolism|2010|374
Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis
|The Lancet Oncology|2016|374
From pituitary adenoma to pituitary neuroendocrine tumor (PitNET): an International Pituitary Pathology Club proposal
|Endocrine Related Cancer|2017|357
Therapeutic and Prognostic Implications of BRAF V600E in Pediatric Low-Grade Gliomas
|Journal of Clinical Oncology|2017|345